Read More Pharma Industry News BrainStorm Cell Therapeutics doses patients in NurOwn phase 3 trial in ALS NurOwn phase 3 trial : BrainStorm Cell Therapeutics, a US biotech company engaged in developing adult stem cell… bypharmanewsdailyJuly 3, 2020